Incidence of rheumatic diseases during the COVID-19 pandemic in South Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The recent coronavirus disease 2019 (COVID-19) pandemic has been associated with changes in the epidemiology of not only infectious diseases but also several non-infectious conditions. This study investigated changes in the recorded incidence of various rheumatic diseases during the COVID-19 pandemic. Methods: The number of patients for each disease from January 2016 to December 2020 was obtained from the Korean Health Insurance Review and Assessment Service database. We compared the incidence of nine rheumatic diseases (seropositive rheumatoid arthritis, systemic lupus erythematosus [SLE], idiopathic inflammatory myositis [IIM], ankylosing spondylitis [AS], systemic sclerosis, Sjögren’s syndrome, Behçet’s disease [BD], polymyalgia rheumatica, and gout) and hypertensive diseases to control for changes in healthcare utilisation before and after the COVID-19 outbreak. The disease incidence before and after the COVID-19 outbreak was compared using the autoregressive integrated moving average (ARIMA) and quasi- Poisson analyses. Results: Compared with the predicted incidence in 2020 using the ARIMA model, the monthly incidence of SLE, BD, AS, and gout temporarily significantly decreased, whereas other rheumatic diseases and hypertensive diseases were within the 95% confidence interval (CI) of the predicted values in the first half of 2020. In age- and sex-adjusted quasi-Poisson regression analysis, the annual incidences of IIM (rate ratio [RR], 0.473; 95% CI, 0.307 to 0.697), SLE (RR, 0.845; 95% CI, 0.798 to 0.895), and BD (RR, 0.850; 95% CI, 0.796 to 0.906) were significantly decreased compared with those in the previous 4 years. Conclusions: The recorded annual incidence of some rheumatic diseases, including IIM, SLE, and BD, decreased during the COVID-19 pandemic.
Abstract
Background/Aims: The recent coronavirus disease 2019 (COVID-19) pandemic has been associated with changes in the epidemiology of not only infectious diseases but also several non-infectious conditions. This study investigated changes in the recorded incidence of various rheumatic diseases during the COVID-19 pandemic. Methods: The number of patients for each disease from January 2016 to December 2020 was obtained from the Korean Health Insurance Review and Assessment Service database. We compared the incidence of nine rheumatic diseases (seropositive rheumatoid arthritis, systemic lupus erythematosus [SLE], idiopathic inflammatory myositis [IIM], ankylosing spondylitis [AS], systemic sclerosis, Sjögren’s syndrome, Behçet’s disease [BD], polymyalgia rheumatica, and gout) and hypertensive diseases to control for changes in healthcare utilisation before and after the COVID-19 outbreak. The disease incidence before and after the COVID-19 outbreak was compared using the autoregressive integrated moving average (ARIMA) and quasi- Poisson analyses. Results: Compared with the predicted incidence in 2020 using the ARIMA model, the monthly incidence of SLE, BD, AS, and gout temporarily significantly decreased, whereas other rheumatic diseases and hypertensive diseases were within the 95% confidence interval (CI) of the predicted values in the first half of 2020. In age- and sex-adjusted quasi-Poisson regression analysis, the annual incidences of IIM (rate ratio [RR], 0.473; 95% CI, 0.307 to 0.697), SLE (RR, 0.845; 95% CI, 0.798 to 0.895), and BD (RR, 0.850; 95% CI, 0.796 to 0.906) were significantly decreased compared with those in the previous 4 years. Conclusions: The recorded annual incidence of some rheumatic diseases, including IIM, SLE, and BD, decreased during the COVID-19 pandemic.
참고문헌 (20)
- 서유빈, "The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease", Infection and Chemotherapy, 52(2), pp.252~280 (2020), 대한감염학회[DOI]
- Kim H, "An increased disease burden of autoimmune inflammatory rheumatic diseases in Korea", Semin Arthritis Rheum, 50, pp.526~533 (2020)
- Rojas M, "Molecular mimicry and autoimmunity", J Autoimmun, 95, pp.100~123 (2018)
- Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
- Huh K, "Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic : a nationwide claims study", Thorax, 76, pp.939~941 (2021)
- Kang JM, "Reduction in Kawasaki disease after nonpharmaceutical interventions in the COVID-19 era : a nationwide observational study in Korea", Circulation, 143, pp.2508~2510 (2021)
- Ullrich A, "Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany : an analysis of national surveillance data during week 1-2016-week 32-2020", Lancet Reg Health Eur, 6, pp.100103~ (2021)
- Zanardo V, "COVID-19 pandemic : impact on gestational diabetes mellitus prevalence", Diabetes Res Clin Pract, 183, pp.109149~ (2022)
- Motazedian G, "Incidence of pediatric perforated appendicitis during the COVID-19pandemic; a systematic review and meta-analysis", Arch Acad Emerg Med, 10, pp.e3~ (2021)
- Hajek A, "Prevalence and determinants of probable depression and anxiety during the COVID-19 pandemic in seven countries : longitudinal evidence from the European COvid Survey(ECOS)", J Affect Disord, 299, pp.517~524 (2022)
- 강영준, "Impact of the COVID-19 Pandemic on the Diagnosis and Surgery of Breast Cancer: A Multi-Institutional Study", Journal of Breast Cancer, 24(6), pp.491~503 (2021), 한국유방암학회[DOI]
- "Daily new confirmed COVID-19 cases per million people" (2022)[URL]
- Birkmeyer JD, "The impact of the COVID-19 pandemic on hospital admissions in the United States", Health Aff(Millwood), 39, pp.2010~2017 (2020)
- Giannouchos TV, "Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system", Am J Emerg Med, 40, pp.20~26 (2021)
- Nourazari S, "Decreased hospital admissions through emergency departments during the COVID-19 pandemic", Am J Emerg Med, 42, pp.203~210 (2021)
- "Number of patients per year" (2020)[URL]
- COVID-19 National Emergency Response Center, "Contact Transmission of COVID-19 in South Korea: Novel Investigation Techniques for Tracing Contacts", Osong Public Health and Research Perspectives, 11(1), pp.60~63 (2020), 질병관리청[DOI]
- Yun HE, "Impact of social distancing on incidence of vaccine-preventable diseases, South Korea", J Med Virol, 93, pp.1814~1816 (2021)
- Huh K, "Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019(COVID-19)outbreak in Korea : a nationwide surveillance study", Clin Infect Dis, 72, pp.e184~e191 (2021)
- Root-Bernstein R, "Complexities in the relationship between infection and autoimmunity", Curr Allergy Asthma Rep, 14, pp.407~ (2014)